News Roundup | FDA Sends Letter Warning Regulators About Doctors & Pharmacies that Market Ivermectin

The U.S. Food and Drug Administration (FDA) is coming for any physician or pharmacy that promotes ivermectin as a drug that can “prevent Coronavirus Disease 2019.” Recently, FDA Acting Branch Chief Shannon Glueck wrote a letter to the Federation of State Medical Boards informing them that they have received complaints that the antiparasitic drug was being offered for sale with claims that it could treat or prevent the novel coronavirus. The FDA is now putting licensing boards on notice.

Letter from the FDA | https://trialsitenews.com/wp-content/uploads/2021/12/Ivermectin-Letter-to-FSMB-Final.pdfJoin us on Rumble! | https://rumble.com/user/TrialSiteNews

...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee